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Aims: Neonates frequently require supplementary oxygen but may develop 
complications if the oxygen saturation is outside the target range. This review aimed 
to determine whether the algorithms used in closed loop automated oxygen control 
systems influenced their efficacy and whether use of the systems reduced relevant, 
long-term neonatal complications. 
Methods: A literature search was conducted using PubMed and Google Scholar.  
The search terms were “closed loop” or “automat*”, “oxygen” and “neonat*”. 
Results:  Eighteen studies were identified: sixteen comparison clinical studies, an 
observational study and an animal study. Overall, closed loop automated oxygen 
control was associated with an increased percentage of time spent within the target 
oxygen saturation range and there were fewer manual adjustments to the inspired 
oxygen concentration when compared with manual oxygen control.  The systems 
were effective in infants on non-invasive respiratory support or mechanically 
ventilated, but no study included term-born infants. No long-term data were 
available to determine if complications of oxygen toxicity were reduced. 
Conclusion:  Closed loop automated oxygen control has been shown in short term 
trials including preterm and low birth weight infants to improve target saturation 
achievement. Whether long term outcomes will be improved with their use requires 
investigation. 
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KEY NOTES  
Closed loop automated oxygen control systems automate the adjustment of the 
inspired oxygen concentrations according to peripheral oxygen saturation levels. The 
systems result in the delivery of supplementary oxygen more often in the desired 
oxygen saturation target levels with less manual intervention. As yet, however, there 
is no evidence that their use reduces long term complications related to 






Neonates with respiratory distress frequently require supplementary oxygen (1), but 
its use can result in development of reactive oxide species (ROS) and complications 
such as bronchopulmonary dysplasia and retinopathy of prematurity (2). Targeting 
oxygen therapy to maintain oxygen saturations (SpO2) within a predefined range 
(SpO2 of 90-95%) can maximise the benefits of increased oxygen delivery to tissues 
whilst minimising the risk of complications (3, 4). As a consequence, in clinical 
practice, peripheral oxygen saturations are continuously monitored and used to guide 
adjustments to the inspired oxygen (FiO2) which are made manually by neonatal 
practitioners. Neonatal patients are prone to frequent fluctuations in oxygen 
saturations, with as many as 600 intermittent hypoxic episodes documented in one 
week in one study (5). Compliance with SpO2 target ranges has been shown to be 
variable even within the same patient over time, as well as between patients and 
centres (6). One quality improvement group found their target saturation range 
achievement was as low as 20% (7). Furthermore, narrowing the target range 
decreases compliance (6) and target achievement decreases as the number of patients 
per nurse increases (8). The shortfalls in target saturation range achievement have 
been suggested to be due to the clinical staff being more tolerant of SpO2 levels 
which are too high rather than too low (9). In one study, upper alarm limits were set 
too high up to 76.5% of the time, whereas lower alarm limits were set correctly 
91.1% of the time (9).  
 
Closed loop automated oxygen control systems use SpO2 values monitored in real 




intervention. The resultant change in SpO2 is monitored and further alterations to the 
FiO2 made as needed. Closed loop automated oxygen control systems may, 
therefore, provide a solution for the low compliance to target oxygen saturation 
level, reduce the need for manual adjustments (and hence workload) and decrease 
complications.   
 
Closed loop automated oxygen control systems continuously monitor SpO2 and the 
data are fed into an algorithm which determines and executes an appropriate 
adjustment to the FiO2. The result of this adjustment is monitored and further 
changes made if needed. The relationship between FiO2 and SpO2 in neonates 
needing respiratory support and supplemental oxygen is non-linear and complex 
(10), hence algorithms are used which reflect this. Several types of algorithm have 
been used.  
 
A systematic review of clinical trials comparing closed loop automated oxygen 
control to manual control confirmed that these systems increase the time spent in 
target SpO2 ranges in prematurely born infants (11). We have undertaken a literature 
review of closed loop automated oxygen control in neonates, aiming to determine 
their efficacy in those born prematurely or at term. Our aims were also to describe 
the algorithms employed and if their performance differed and whether use of closed 
loop automated oxygen control resulted in reductions in adverse outcomes, as well as 









Literature searches were completed on Google Scholar and Pubmed using the terms 
“closed loop” or “automat*” and “oxygen”, “neonat*”. Included studies were those 
comparing the use of closed-loop automated oxygen control systems with manual or 
steady-state oxygen control.  The inclusion criteria were published studies that 
compared the use of closed-loop oxygen monitoring devices to manual or steady-
state (unchanged) oxygen control with measured outcomes of time spent within 
target oxygen saturation range and/or number of manual adjustments to the fraction 
of inspired oxygen.  Exclusion criteria were studies that either did not involve 
neonatal patients or animal studies which did not model neonatal patients’ 
respiratory diseases.  One thousand, one hundred and forty results were identified. 
Abstracts were screened for relevance and duplicates removed. One hundred and 
forty-three studies remained, but only nineteen were studies of closed loop 




Eighteen studies were identified as relevant to neonatal practice: sixteen comparison, 
clinical studies, an observational study and an animal study. All the clinical studies 
were in infants of gestational ages between 23 and 30 weeks, that is there were no 







1. Algorithms used in closed loop automated oxygen monitoring 
 
Rule-based algorithms 
Rule-based, fuzzy algorithms operate by measuring the error and making an 
adjustment based on the magnitude of the error (12, 13). Fuzzy logic is used to 
represent the idea that a statement could vary from completely true to completely 
false, including being partially true or partially false, whereas non-fuzzy logic only 
enables a statement to be defined as ‘true’ or ‘false’. This approach is helpful for 
systems which have non-linear relationships, such as the relationship between SpO2 
and FiO2 in a neonate (14). This allows the knowledge and expertise that medical 
staff have to translate more easily into an algorithm (13), as staff would describe a 
patient’s SpO2 level as being slightly low or extremely low rather than ‘just’ low. 
 
Rule-based algorithms determine adjustments based on the current SpO2 and the 
trend of SpO2 levels. The trend is calculated from the size of the error (how far away 
the SpO2 is from the mid-point of the target range), its velocity and its acceleration.  
The trend determines what adjustment, if any, is made to the FiO2 (14). For example, 
a closed-loop automatic control (CLAC) algorithm used in a randomised controlled 
trial (15) determined whether the SpO2 was in the normal range, above or below 
(including the magnitude of the error) and whether it was increasing, decreasing or 
stable and then suggested five possible FiO2 adjustments from -0.02 to +0.05.  
Additionally, the algorithm recognised when the SpO2 signal was poor and excluded 
those readings (15). Similar rule-based algorithms have been used in preterm lambs, 




control compared with manual control during a period of stable ventilation (post-
resuscitation) (16). 
 
Proportional-integral-differential (PID) algorithms 
PID algorithms use the error, its integral and its derivative to determine the output, 
with multiplying coefficients (or gains) applied to each of the inputs). The error, as 
in rule-based algorithms, is the difference between the current SpO2 and the 
midpoint of the target SpO2 range. Some PID algorithms automatically adjust the 
gains over time in order to re-model the algorithm appropriately for that patient’s 
respiratory system (17). 
 
Adaptive model algorithms 
Adaptive model control algorithms aim to model the patient’s relationship between 
FiO2 and SpO2 based on the oxygen dissociation curve. The adaptive control model 
algorithm uses this curve to determine how much the FiO2 needs to be adjusted to 
cause the desired change in SpO2 and adjusts the model at set intervals (every two to 
five minutes) to make it more accurate for that particular patient (18).   
 
Comparison of algorithms 
All three algorithms have been shown to increase the amount of time spent in the 
target saturation range (10) and decrease the number of manual interventions 
required (10). The adaptive model control algorithm has been shown to result in the 
largest increase in time spent within the target saturation range compared to manual 
control (60% compared to manual control, whereas the PID algorithm achieved 52% 




Additionally, the adaptive model algorithms require no setup, as the algorithm 
automatically adjusts to the patient’s response (10).   
 
2 Accuracy of closed loop automated oxygen therapy 
Sixteen single or multicentre clinical studies have been undertaken comparing closed 
loop automated oxygen control to manual oxygen control in neonates to determine 
whether automating FiO2 control was associated with a greater target SpO2 
achievement. They consistently demonstrated that closed loop automated oxygen 
control maintained the patient within their target SpO2 range a significantly greater 
proportion of the time than manual control (10, 12, 15, 16, 19-30). Closed loop 
automated oxygen control has been demonstrated to reduce hyperoxic episodes, in 
one study almost halving the frequency (9.3 to 4.7 episodes per 90 minutes) and the 
duration (19.3s to 10.1s) of hyperoxic episodes (21) and in another study reducing 
the median percentage time spent with an SpO2 >95% from 41.9% to 19.3% 
(p<0.001) (28). A randomised crossover study found that an automated controller 
resulted in ‘overshoot’ (an exaggerated response to hypoxia leading to hyperoxia) 
more frequently than manual control, but the resulting episodes of hyperoxia were 
shorter than similar episodes under manual control (30).   
 
A systematic review (11) of closed loop automated oxygen control studies found that 
automated control of FiO2 resulted in a significantly higher time spent in the target 
saturation range (mean difference (MD) 12.8%, 95% CI 6.5-19.2%). It also found 
that automated control resulted in significantly reduced periods of hyperoxia (MD:  -
8.8%; 95% CI: -15 to -2.7%), severe hypoxia (MD: -0.9%; 95% CI: -1.5 to -0.4%) 




study, however, found that automated control was associated with an increase in the 
number of episodes of hypoxia, although there was no increase in the episodes of 
extreme hypoxia (SpO2<80% or <75%) (23).   
 
Applying automated O2 under different conditions 
Automated systems have been shown to increase the percentage of time spent in the 
target oxygen saturation range for patients at a range of postnatal ages, despite 
oxygen stability varying with postnatal age. As before, none of these studies have 
included term born infants. They have also been shown to be effective for infants 
who were intubated and ventilated (10, 20, 22-24), as well as those on non-invasive 
respiratory support (12, 19, 21, 25, 27, 30). In a randomised trial of a closed loop 
automated oxygen control system for infants on non-invasive respiratory support, 
infants on automated control spent a significantly higher proportion of their time 
within their target saturation range compared to those on manual control (58% 
versus 33.7% respectively) (12). The automated system was also associated with a 
reduction in the frequency and duration of episodes of hyperoxia (12).  
 
Comparison with optimum manual control 
Automated oxygen control has been compared with routine manual control as 
described above, but also with optimum manual control that is one to one dedicated 
attention to FiO2 adjustment. Automated control was superior to one-to-one attention 
to oxygen adjustment in maintaining SpO2 within the target range (81% of the time 
versus 69%) (17). A study of automated control in preterm infants on non-invasive 
respiratory support found that it provided a significantly increased percentage of 




55% in the target SpO2 range, p=0.0001) (27). In that study, prolonged periods 
outside of the target saturation range were almost eliminated by automated control 
with no 60-second episodes with SpO2 levels >96% or <85% and fewer than two 
episodes lasting 30 seconds (27). This suggests that even with the best possible 
staffing ratios, automated oxygen control will still confer a benefit to patients. 
 
Comparison with different oxygen saturation ranges 
A crossover trial of infants with closed loop automated SpO2 control compared two 
target saturation ranges: 87-93% and 90-93% (31). The tighter target range narrowed 
the distribution of SpO2 values, but did not result in any significant reduction in the 
frequency or duration of episodes of desaturation, increase the time spent within the 
target SpO2 range, or decrease the time spent at extremes of SpO2 (31). A further 
study compared two other target SpO2 ranges: 89-93% and 91-95% (25). The 
automated oxygen control system significantly increased the time spent within the 
target saturation range with both target SpO2 ranges compared to manual control 
(25). The effect was larger in those with the lower target SpO2 range group (a 
difference of 8% compared to 4% more time in the target saturation range), although 
this appeared to be due to less effective manual control in that group (25).   
 
Supplementary oxygen weaning 
A crossover study found that with automated weaning, infants spent significantly 
more time with a FiO2 <0.25 than with manual control (23). A further crossover 
study of automated FiO2 control versus manual control in infants on nasal cannula 
oxygen found that, in addition to automated control resulting in a significantly 




control also tended to result in a FiO2 of 21%, whereas manual control resulted in an 
FiO2 of 30% (30). Those results suggest automated control might identify which 
patients no longer require supplementary oxygen more quickly. The results of a 
systematic review of automated control, however, did not demonstrate a significant 
difference in FiO2 exposure or time spent below the target SpO2 range (11).  More 
evidence is required to determine whether automated control will aid weaning and in 
which groups of patients. 
 
Other outcomes 
No data were reported on adverse effects of closed-loop oxygen control, although the 
majority of the included studies provided the option for manual overriding of the 
automated systems in the case of an unsafe alteration to the FiO2.  No data were 
found on the long-term clinical outcomes for infants with closed-loop oxygen control 
as compared to those with conventional manual control.   A large, multicentre 
randomised controlled trial including long-term outcomes is underway and expects 
to complete in 2022 (32). 
 
 
3. Decrease in staff workload 
Multiple studies have found that automated oxygen control systems lead to a 
decrease in the number of manual interventions made by staff (10, 12, 15, 
20, 21, 23-25, 27, 29). Studies have reported that clinical staff needed to adjust the 
FiO2 less than once per hour when there was automated control (10, 12, 21, 24, 27, 
29), compared to as many as 29 times per hour during manual control (20). A 




made 7,540 FiO2 adjustments in a 12-hour period, whereas staff made 80 
adjustments over the same time period in the manual control group (12). 
Furthermore, the staff did not make any manual adjustments to the automated control 
group’s FiO2 (12), suggesting that they thought the automated adjustments were all 
deemed appropriate.  
 
In a crossover study, staff adjusted the FiO2 2.3 times/hour during manual control, 
whereas the automated system adjusted the FiO2 64 times/hour (27). The frequency 
of adjustments may contribute to the overall increase in target saturation 
achievement with automated oxygen control (11). No evidence, however, was 
available to suggest that the reduction in manual interventions resulted in neonatal 
practitioners having a reduced workload and hence able to use that time for other 
care activities.  
 
4. Critical analysis of included studies 
 
Similarly, to Mitra’s systematic review, we found a high risk of bias.  This was 
mostly due to the fact that, although the majority of studies were randomised 
crossover studies, few details of the randomisation process and sequence generation 
were described.  One study was observational, therefore, introducing a risk of 
confounding factors (such as gestational age or disease state) although the authors 
did report that the demographics of the two sets of patients were not statistically 







This review highlights that automated oxygen control does increase the percentage 
of oxygen saturation levels within the target range. It should be noted, however, that 
even with automated systems the time infants spend in the target span of SpO2 is still 
far from satisfactory and that there is much room for improvement.  It also reduces 
the number of manual modifications made to the FiO2, but whether this reduces the 
nursing workload enabling improvements in clinical outcome by nurses being able to 
concentrate on other tasks has not been documented. Furthermore, whether 
automated oxygen control reduces long term complications has not been 
investigated.  
 
There are, however, some concerns regarding automated oxygen control. Body 
movement is known to be a common cause of disruption of SpO2 signal, but it can 
also be associated with hypoxaemia. Some automated systems are designed not to 
adjust FiO2 if the SpO2 signal is of a poor quality. Therefore, there could be a delay 
in reaction to hypoxaemia until the signal quality is restored (33). Episodes of 
desaturation are commonly used as a potential warning sign of infection or 
respiratory deterioration (34). An automated FiO2 system could potentially ‘mask’ 
this important clinical sign by maintaining the SpO2 within the target range.  
Therefore, some systems have additional alarm features to signal a significant 
increase in FiO2 even if the SpO2 remains within the target range. For example, one 
system activates an alarm if there is an increase in FiO2 of ≥0.3 from the basal level 





In conclusion, automated oxygen control does reduce the time spent in which the 
oxygen saturation level is outside the target range. It is, however, important to 
determine whether this improves long term complications related to oxygen toxicity 
and if use of such systems reduces nurse workload which translates into improved 
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LIST OF ABBREVIATIONS   
CLAC Closed loop automatic control 
CPAP Continuous positive airway pressure 
FiO2 Fractional concentration of inspired oxygen 
MD Mean difference 
NCPAP Nasal continuous positive airway pressure 
PaO2 Partial pressure of oxygen in arterial blood 
PID Proportional integral differential 
RDS Respiratory distress syndrome 
ROS Reactive oxide species 
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Population N Algorithm 
% time spent in target SpO2 
range 
Number of manual 
adjustments Results 

















period * • Increased time within target range with 
all three algorithms tested compared to 
manual control 
• All algorithms significantly reduced time 
spent in hyperoxaemia 































33.7** 58.0** 80/120h  0/120h 
• Increased time within target range with 
automated control 
• Reduced frequency and duration of 
hyperoxic episodes 
• Fewer episodes of SpO2 70-75% with 
automated control, but increased 



















61.0*** 72.1*** 77/24h* 52/24h* 
• Significant increase in mean time spent 
in target SpO2 range shown in 3 out of 4 
participating centres 
• Lowest effect seen in centre with lowest 
SpO2 target range 
• Significant reduction in time spent 














 84.0* 93.2*  13.0/h 5.7/h 
• Increased time within target range with 
automated control during steady-state 
ventilation 
• Automated FiO2 feasible to be used 















14 Adaptive 69 81 - - 
• Adaptive control increased time spent 
within the target range compared to 
manual control 














57  71  3.74/h  0.48/h • All three algorithms tested increased 
time spent within target range when 
compared to manual control 
• As the target range increased, the three 
algorithms converged towards 
equivalent performance 
• Adaptive model did not require manual 





57 70  3.74/h 0.45/h 












 12 Rule-based  72.4**  87.8** - - 
• Increased time within target range with 
automated control 
• Reduced time with PaO2 below target 
range with automated control 
• No significant difference in time with 
PaO2 above target range 
• Shorter duration of episodes outside of 























66.3* 74.9* 29/h n/a 
• Increased percentage of time spent in 
normoxaemia with automated control 
• No significant difference in frequency or 
duration of hypoxaemic or 
hyperoxaemic episodes 


















81.7* 90.5* 3.0/h*** 0.3/h*** 
• 11% increase in time spent within target 
range with automated control 
• Reduced frequency and duration of 
hyperoxic episodes 

















42*** 58*** 7/4h*** 34/4h*** 
• Increased time within target range with 
automated control 
• Reduced time in hyperoxaemia and time 
spent with SpO2 above the target range 
with automated control 
• Increased frequency of episodes with 
SpO2 <88% with automated control 
• Slight decrease in duration of 

















32*** 40*** 112/24h*** 10/24h*** 
• Increased time within target range with 
automated control 
• Reduced duration of hyperoxia 
• Consistently lower FiO2 throughout the 
study period with automated FiO2 

















 59.6* 72.8* 63/12h** 0/12h** 
• Increased time within target range with 
automated control 
• Reduced time with SpO2 >98% or <80% 
• Reduced prolonged episodes of 



























 - - 
• Mean within subject difference was 
significantly larger in the 89-93% target 
group 
• Reduced time in hypoxaemia and 
hyperoxaemia 
• In the 89-93% target group only: 
reduced time above target range, 
reduced severe hyperoxaemia and 
























69.1** 76.3** - - 
• Increased time within target range with 
automated control 
• Reduced time in hyperoxaemia 
• Reduced prolonged periods with SpO2 
<88% 
• No significant difference in cerebral 
















 55**** 78**** 2.3/h 0.24/h 
• Increased time within target range with 
automated control 
• Reduced SpO2 coefficient of variation 
• Reduced time spent with SpO2 < 80% or 
>98% 
















48.4** 62.0**  - - 
• Increased time within target range with 
automated control 
• Reduced time with SpO2 above target 
range 






















68.52** 77.83** 7.5/h*** 0.5/h*** 
• Reduced time in hypoxaemia, including 
a reduction in prolonged periods of 
hypoxaemia >60s and >180s duration 
• No significant difference in time spent 
above the target SpO2 range 
• No significant difference in hepatic or 
cerebral tissue oxygen saturation 






















 49**** 80**** 1.6/h**** 0/h**** 
• Increased time within target range with 
automated control 
• Reduced variation of SpO2 values 
• Reduced time below target range and 
with SpO2 <80% 
• Reduced time with SpO2 above target 
range 
• No significant difference in frequency of 
episodes of hyperoxaemia 
* = p < 0.05 
** = p < 0.01 
*** - p<0.001 
****- p<0.0001 
 
 
 
 
